Oral amino acid administration in patients with diabetes mellitus: supplementation or metabolic therapy
Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects
In some embodiments, the lipid-based drug delivery formulation or composition has a viscosity of at least about 10,000 centipoise, at least about 20,000 centipoise, at least about 30,000 centipoise, at least about 40,000 centipoise, at least about 50,000 centipoise, at least about 60,000 centipoise, or at least about 70,000 centipoise, all at 58 C., without the presence of any methyl-cellulose or other viscosity enhancing agents
These medications work by increasing insulin production, lowering glucagon secretion, and targeting appetite-regulating brain areas
I know I already mentioned pasta in this article, but I really do love it
A previous version of this story misstated the timeline.